Portfolio Update

RNS Number : 9372Y
Intl. Biotechnology Trust PLC
14 September 2020
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Portfolio Update

 

The Company notes the announcement made by Gilead Sciences, Inc. (NASDAQ: GILD) to acquire Immunomedics (NASDAQ: IMMU) on 13 September 2020. The Company held 316,000 shares in Immunomedics as at the market close on Friday 11 September 2020.

 

The August 2020 Factsheet released this morning reflected that the Company had owned 475,000 shares in Immunomedics as at 31 August 2020.

 

 

 

SV Health Managers LLP

Investment Manager

Tel: 020 7421 7070

Email: IBT-IR@svhealthinvestors.com

 

BNP Paribas Secretarial Services Limited

Company Secretary 

Tel: 020 7410 5971  

 

14 SEPTEMBER 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBXGDCIDBDGGS

Companies

International Biotech Trust (IBT)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today